http://bjsm.bmj.com/content/38/3/253.abstract

http://www.ncbi.nlm.nih.gov/pmc/arti...v038p00253.pdf

In a randomised double blind, placebo controlled design, the effects of intramuscular administration of nandrolone decanoate (200 mg/week) for eight weeks on the same variables in 16 bodybuilders were studied (study 2). Fasting serum concentrations of total cholesterol, triglycerides, HDL-cholesterol (HDL-C), HDL2-cholesterol (HDL2-C), HDL3-cholesterol (HDL3-C), apolipoprotein A1 (Apo-A1), apolipoprotein B (Apo-B), and lipoprotein (a) (Lp(a)) were determined.

In study 2, nandrolone decanoate did not influence serum triglycerides, total cholesterol, HDL-C, HDL2-C, HDL3-C, Apo-A1, and Apo-B concentrations after four and eight weeks of intervention, nor six weeks after withdrawal. However, Lp(a) concentrations decreased significantly from 103 (68) to 65 (44) U/l in the nandrolone decanoate group, and in the placebo group a smaller reduction from 245 (245) to 201 (194) U/l was observed. Six weeks after the intervention period, Lp(a) concentrations had returned to baseline values in both groups.

What would the risk be if the dose were increased and the length of use were increased?

Is 200mgs/week for 8 weeks enough to produce results?

Sine the studies on testosterone showed little effect on blood lipids at doses of 600mg/week could one combine 200mgs of nandrolone with 400mgs of testosterone ethanate and see good results on an 8 week cycle with liitle change in blood lipid profile?